Cargando…
LOXL2 silencing suppresses angiotensin II-induced cardiac hypertrophy through the EMT process and TGF-β1/Smad3/NF-κB pathway
OBJECTIVE(S): Atrial fibrillation (AF) is a common arrhythmia with atrial myocyte hypertrophy linked with stroke, heart failure, and increased mortality. Lysyl oxidase-like 2 (LOXL2) involves the cross-linking of collagen in the extracellular matrix (ECM). In the present study, we investigated the r...
Autores principales: | Luo, Jun, Wu, Yingbiao, Zhu, Xi, Wang, Saihua, Zhang, Xiaogang, Ning, Zhongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464345/ https://www.ncbi.nlm.nih.gov/pubmed/36159334 http://dx.doi.org/10.22038/IJBMS.2022.63338.13981 |
Ejemplares similares
-
Irisin attenuates angiotensin II-induced atrial fibrillation and atrial fibrosis via LOXL2 and TGFβ1/Smad2/3 signaling pathways
por: Wu, Yingbiao, et al.
Publicado: (2023) -
Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway
por: Hai, Zhen, et al.
Publicado: (2023) -
BRD4 Silencing Protects Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting TLR4/NF-κB and Activating Nrf2-HO-1 Pathways
por: Fang, Ming, et al.
Publicado: (2022) -
Angiotensin Inhibition, TGF-β and EMT in Cancer
por: Pallasch, Fabian Bernhard, et al.
Publicado: (2020) -
Petchiether A attenuates obstructive nephropathy by suppressing TGF‐β/Smad3 and NF‐κB signalling
por: You, Yong‐Ke, et al.
Publicado: (2019)